| CTRI Number |
CTRI/2021/10/037529 [Registered on: 25/10/2021] Trial Registered Prospectively |
| Last Modified On: |
24/10/2021 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
To rule out the effect of Vasaghrita in Urdhvag Amlapitta(Hyperacidity)according to Chakradatta |
|
Scientific Title of Study
|
Study of Trisutra in Urdhvag Amlapitta and its management by Vasaghrita w.s.r. to Chakradatta |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Deepak Yadav |
| Designation |
PG SCHOLAR |
| Affiliation |
Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H) Wardha |
| Address |
Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital and Research Centre Salod (H) Datta Meghe Institute of Medical Sciences Wardha Nagpur Maharashtra India
Wardha MAHARASHTRA 442004 India |
| Phone |
7974154869 |
| Fax |
|
| Email |
dy3385640@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Preeti Borker |
| Designation |
PROFESSOR |
| Affiliation |
Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H) Wardha |
| Address |
Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital and Research Centre Salod (H) Datta Meghe Institute of Medical Sciences Wardha Nagpur Maharashtra India
Wardha MAHARASHTRA 442004 India |
| Phone |
8446127058 |
| Fax |
|
| Email |
preetiborkar1977@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Preeti Borker |
| Designation |
PROFESSOR |
| Affiliation |
Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H) Wardha |
| Address |
Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital and Research Centre Salod (H) Datta Meghe Institute of Medical Sciences Wardha Nagpur Maharashtra India
Wardha MAHARASHTRA 442004 India |
| Phone |
8446127058 |
| Fax |
|
| Email |
preetiborkar1977@gmail.com |
|
|
Source of Monetary or Material Support
|
| Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H.) Wardha |
|
|
Primary Sponsor
|
| Name |
Mahatma Gandhi Ayurved College Hospital Research Centre Salod H Wardha |
| Address |
Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H.) Wardha |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Deepak Yadav |
Mahatma Gandhi Ayurved Hospital and Research Center |
Room No 2 First Floor Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H.) Wardha Wardha MAHARASHTRA |
7974154869
dy3385640@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICAL COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K219||Gastro-esophageal reflux disease without esophagitis. Ayurveda Condition: Urdhavag Amlapitta , |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Vasaghrita, Reference: (Bhaishajya Ratnavali Slok no. 124) (13 Chapter), Route: Oral, Dosage Form: Ghrita, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: 2 visits during treatment each after 7 days and 2 follow up each after 7 days of treatment. |
|
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
64.00 Year(s) |
| Gender |
Both |
| Details |
1 Patient age above 20 yrs. and below 65 yrs.
2 both sexes will be selected.
3 Patient suffering from typical signs and symptoms of Amlapitta
|
|
| ExclusionCriteria |
| Details |
1 Patient age group below 20 yrs. and above 65 yrs. were excluded.
2 Pregnant and lactating mother.
3 Patients suffering from chronic diseases such as diabetes, hypertension, IHD, chemotherapy and major operative procedure etc., were excluded.
4 Irregular patients not providing proper data were excluded.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Effect of Vasaghrita in Urdhvag Amlapitta |
2 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Effect of Vasaghrita in Urdhvag Amlapitta in all types of Parameters |
2 weeks |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
25/10/2021 |
| Date of Study Completion (India) |
31/03/2023 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
NOT YET |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
BRIEF SUMMARY ON PURPOSE -
Ayurveda is an ancient science of life that focuses on the primary goal of "Dhatushamyata"1 for living a long and healthy life. Ayurveda offers numerous concepts regarding dhatu balance and illness management, which includes three main pillars (Hetu, Linga, and Aushadha2) that aid in the understanding of disease symptoms and therapy. Hetu as causal causes, Linga as particular symptoms, and Ashudh as medication and illness therapy are the three components of the Trisutra. BACKGROUND OF TRIAL -
Literature and Interventional study. Study design
Literature review of Urdhavags Amlapita Clinical study
Assessment of patient as per inclusion and exclusion criteria
Inform consent
Treatment duration 14 days through oral route
vasa ghrita 10ml in the morning along with nidanparivarjan and pathyapathya 2 visits during treatment each after 7 days 2 Follow up after 7 days each after treatment
Generation of statistical data
Statistical analysis
Discussion
Conclusion and Summary Sampling procedure: Simple random sampling. Sample size (Including sample size calculation): 60 Patients. Grouping & Posology: | Group | Sample size | Intervention | Dose and Frequency | Anupana | Duration | Follow up | | Trial drug | 60 | Vasaghrita 10 ml | 10 ml once a day | Lukewarm water | 14 Days | 2 visits during treatment each after 7 days and 2 follow up each after 7 days of treatment. | Data collection tools and process: - From the OPD & IPD of Mahatma Gandhi Ayurved college hospital and research Centre, Salod, Wardha. Gradations of symptoms. | Sr.no | Sign/Symptoms | Grading | | 1 | Vanti - | 0 absent 1 once/week or less quantity 2 2-3 times/week or moderate 3 > 3 times/week or profuse | | 2 | Shiroruja, | 0 - Absent 1 Occasional 2 Intermittent 3 Continuous affecting routine work | | 4 | Kar - charandaha, | 0 Absent 1 Occasional 2 Intermittent 3 Continuous affecting routine work | | 4 | Sarvangdaha | 0 - Absent 1- Occasional 2- Intermittent 3- Continuous affecting routine work | | 5 | Hridkanthadaha | 0 - Absent 1- Occasional 2- Intermittent 3- Continuous affecting routine work | | 6 | Aruchi | 0- Absent 1- Occasional 2- Intermittent 3- Continuous affecting routine work | | 7 | Tikta - amlaudgar | 0 - Absent 1- Occasional 2- Intermittent 3- Continuous affecting routine work | | 8 | Kandu, | 0 - Absent 1- Occasional 2- Intermittent 3- Continuous affecting routine work | | 9 | Jvara - | 0– absent 1- 99˚- 100˚F 2--101˚-103˚F 3 - >103˚F | | 10 | Mandal | 0 - absent 1 - 1-2mm 2 - up to 3mm 3 - up to 5mm | | 11 | Pidaka | 0 - skin colour 1 - hyperaemic 2 - red 3 - dark red |
FINDINGS -
Primary Outcomes: We will see the Significant effect of vasa ghrita on Amlapitta, Secondary Outcomes: We will see the effect of vasa ghrita on Amlapitta all types of parameters
|